China claims that four GlaxoSmithKline executives are involved in a massive bribery scheme to boost drug sales including travel costs, meeting expenses, and sexual favors going back over five years. Glaxo, for its part, is taking a tough stance, touting its zero-tolerance policy and sending key executives to personally handle the situation. 全球知名药企葛兰素史克中国行贿事件持续发展,警方日前进一步披露葛兰素史克(中国)投资有限公司(下称葛兰素史克中国)部分高管涉嫌经济犯罪案情。包括葛兰素史克中国4名高管在内,超过20名药企和旅行社工作人员被警方立案侦查,涉及金额达1.19亿元。外资药企“四驾马车”同时被抓,这还是首次。这些高管涉嫌受贿,并用受贿所得再行贿政府官员和医生等,其中还有人涉嫌接受性贿赂。警方表示,药价虚高与药企行贿不无关系。(文字来源深圳日报) ======================= 曾经很关注Gsk的股票行情,我觉得是拉米救过我,一直想买100股Gsk的股票报恩,但一直都没有那么多钱。现在发现它出麻烦,很吃惊。不过Gsk股票价格没有变化。
|